Frequency of biologic switching and the outcomes of switching in children and young people with juvenile idiopathic arthritis: a national cohort study

Lianne Kearsley-Fleet, Eleanor Heaf, Rebecca Davies, Eileen Baildam, Michael W. Beresford, Helen E. Foster, Taunton Southwood, Wendy Thomson, Kimme Hyrich, Biologics for Children with Rheumatic Diseases Study (BCRD), British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study (BSPAR-ETN)

Division of Musculoskeletal & Dermatological Sciences (L5)

Research output: Contribution to journal › Article › peer-review

5 results
- Title
- Date(ascending)

No Evidence to Support Biologic Switching Guidelines for JIA
Lianne Kearsley-Fleet
1/04/20
1 Media contribution
Press/Media: Other
Neither first nor second biologic beneficial for many with JIA
Lianne Kearsley-Fleet
25/03/20
1 item of Media coverage
Press/Media: Other
One-Fifth of JIA Patients Switch Out 1st Biological Therapy, UK Study Reports
Lianne Kearsley-Fleet
20/03/20
1 Media contribution
Press/Media: Other
Biologic switching in JIA: does changing class affect outcomes?
Lianne Kearsley-Fleet
19/03/20
1 Media contribution
Press/Media: Other
EULAR 2019 News Coverage
Lianne Kearsley-Fleet
12/06/19 → 14/06/19
2 items of Media coverage
Press/Media: Other